Antares Pharma reported $4.42M in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2100M 911M
Abbvie ABBV:US $ 3179M 2413M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Adma Biologics ADMA:US $ -17.71M 1.19M
Aerie Pharmaceuticals AERI:US $ -39.69M 1M
Ani Pharmaceuticals ANIP:US $ -4.45M 9.66M
Atrion ATRI:US 8.28M 647K
Becton, Dickinson and BDX:US $ 265M 260M
Cerus CERS:US $ -12.44M 2.92M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Endo International Ordinary Shares ENDP:US $ -77.21M 61.71M
Horizon Pharma HZNP:US $ 326.54M 168.43M
JAZZ PHA JAZZ:US $ -52.83M 310.48M
Meridian Bioscience VIVO:US $ 6.66M 5.01M
Orasure Technologies OSUR:US $ -15.02M 13.65M
Pacira Pharmaceuticals PCRX:US $ 17.66M 1.42M
Pfizer PFE:US $ 8146M 2582M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Rockwell Medical RMTI:US $ -7.58M 0.82M
Sientra SIEN:US $ 28.41M 48.54M
Staar Surgical STAA:US $ 6.02M 2.55M
Supernus Pharmaceuticals SUPN:US $ 21.56M 2.16M
Teva Pharmaceutical TEVA:IT 290M 83M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M
Zogenix ZGNX:US $ -58M 0.89M